Department of Medicine, University of Cambridge, Cambridge, United Kingdom
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
J Clin Microbiol. 2018 Feb 22;56(3). doi: 10.1128/JCM.01520-17. Print 2018 Mar.
Vancomycin-resistant (VREfm) bloodstream infections are associated with high recurrence rates. This study used genome sequencing to accurately distinguish the frequency of relapse and reinfection in patients with recurrent bacteremia and to investigate strain relatedness in patients with apparent VREfm and vancomycin-susceptible (VSEfm) mixed infection. A retrospective study was performed at the Cambridge University Hospitals NHS Foundation Trust (CUH) between November 2006 and December 2012. We analyzed the genomes of 44 isolates from 21 patients (26 VREfm isolates from 12 patients with recurrent bacteremia and 18 isolates from 9 patients with putative VREfm/VSEfm mixed infection). Phenotypic antibiotic susceptibility was determined using a Vitek2 instrument. Genomes were compared with those of a further 263 isolates associated with bacteremia in patients at CUH over the same time period. Pairwise comparison of core genomes indicated that 10 (71%) episodes of recurrent VREfm bacteremia were due to reinfection with a new strain, with reinfection being more likely with increasing time between the two positive cultures. The majority (78%) of patients with a mixed VREfm and VSEfm infection had unrelated strains. More than half (59%) of study isolates were closely related to another isolate associated with bacteremia from CUH. This included 60% of isolates associated with reinfection, indicating acquisition in the hospital. This study provides the first high-resolution insights into recurrence and mixed infection by and demonstrates that reinfection with a new strain, often acquired from the hospital, is a driver of recurrence.
万古霉素耐药(VREfm)血流感染与高复发率相关。本研究使用基因组测序来准确区分复发性菌血症患者的复发和再感染频率,并调查明显 VREfm 和万古霉素敏感(VSEfm)混合感染患者的菌株相关性。在剑桥大学医院 NHS 基金会信托(CUH)于 2006 年 11 月至 2012 年 12 月期间进行了一项回顾性研究。我们分析了 21 名患者(12 名复发性菌血症患者中 26 株 VREfm 分离株和 9 名疑似 VREfm/VSEfm 混合感染患者中的 18 株分离株)的 44 株分离株的基因组。使用 Vitek2 仪器测定表型抗生素敏感性。将基因组与同一时期 CUH 患者菌血症相关的另外 263 株分离株进行比较。核心基因组的两两比较表明,10 例(71%)复发性 VREfm 菌血症是由于新菌株的再感染引起的,两次阳性培养之间的时间间隔越长,再感染的可能性越大。大多数(78%)混合 VREfm 和 VSEfm 感染的患者具有不相关的菌株。超过一半(59%)的研究分离株与来自 CUH 的另一个与菌血症相关的分离株密切相关。这包括与再感染相关的分离株的 60%,表明在医院获得。本研究首次提供了对 和混合感染复发的高分辨率见解,并表明与新菌株的再感染(通常从医院获得)是复发的驱动因素。